Brain cell transplant trial offers new hope for Parkinson's patients
NCT ID NCT05635409
Summary
This is the first-ever human trial of a new stem cell therapy for Parkinson's disease. Researchers will transplant lab-grown cells that can become dopamine-producing brain cells directly into the brains of eight participants. The main goal is to test if this procedure is safe, while also looking for early signs that it might help control Parkinson's symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cambridge University Hospitals NHS Foundation Trust
Cambridge, Cambridgeshire, CB2 0QQ, United Kingdom
-
Region Skåne - Skåne University Hospital
Lund, 214 28, Sweden
Conditions
Explore the condition pages connected to this study.